Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis.

IF 5.1 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2026-09-01 DOI:10.1038/s41409-026-02979-x

Jan Christian Schroeder, Christophe Peczynski, Philipp Berning, Eva Michel, Fizza Imran, Lucas Mix, Andreas Riedel, Robin Sanderson, Urban Novak, Ron Ram, Maria-Luisa Schubert, Maxime Delforge, David Beauvais, Daniela Taurino, Robin Noel, Lucia Lopez Corral, Almudena Cabero, Ralph Wäsch, Malte von Bonin, Peter Vandenberghe, Olaf Penack, Björn Chapuy, Avichai Shimoni, Barbara Dreta, Ulf Schnetzke, Eugenio Galli, Tobias Holderried, Claudia Lengerke, Norbert Schmitz, Wolfgang Andreas Bethge

引用次数: 0

查看原文本刊更多论文

大b细胞淋巴瘤的CD19 CAR-T后的靶向免疫治疗暴露和结果：EBMT注册分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.